MedTrace Logo

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

NCT00865488 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-12-23

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and efficacy of ADHEXIL™ in preventing and/or reducing post-operative adhesions in patients undergoing surgery involving the ovaries.

Conditions

  • Ovarian Cysts
  • Endometriosis
  • Adhesions

Interventions

BIOLOGICAL

ADHEXIL

Adhesions prevention

Sponsors & Collaborators

  • OMRIX Biopharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Eran Kurman, B.med.Sc, MBA · OMRIX Biopharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-02-28
Completion
2010-04-30

Countries

  • United States
  • Germany
  • Mexico
  • Russia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00865488 on ClinicalTrials.gov